FamiCord AG

V3V

Company Profile

  • Business description

    FamiCord AG is an umbilical cord blood bank. It supplies cryopreservation and provides logistics for the collection of blood, preparation, and storage of stem cells from umbilical cord blood and tissue. The company is active in the areas of cell and gene therapies and CDMO. It continues to develop from a pure stem cell bank into a more broadly based cell bank that can supply available patients own cells for current and future cell therapies. Its services include stem cells banking, stem cells scientific proof, FamiCord contribution, stem cell applications list, stem cell applications stories, and stem cells banking for society. Its segments include Subgroup Vita 34 and Subgroup PBKM, which generate maximum revenue. It operates in Germany, Poland, Switzerland, and other foreign countries.

  • Contact

    Perlickstrase 5
    LeipzigD-04103
    DEU

    T: +49 34148792

    E: [email protected]

    https://www.famicord.com

  • Sector

    Healthcare

    Stock type

    Defensive

  • Industry

    Medical Care Facilities

    Fiscal Year End

    31 December 2026

    Employees

    742

Stocks News & Analysis

stocks

Alphabet raises $80 billion for AI efforts

$10 billion private placement to Berkshire Hathaway as part of equity raise.
stocks

Undervalued ASX healthcare provider

Solid demand profile for global leader.
stocks

SpaceX: What investors need to know about its enormous upcoming IPO

Morningstar launches research coverage of SpaceX.

Morningstar Investment Ideas

Markets

Index
Last price
Change
% Change
All Ordinaries9,017.203.10-0.03%
CAC 408,180.0229.07-0.35%
DAX 4024,870.70253.47-1.01%
Dow JONES (US)51,307.79228.910.45%
FTSE 10010,333.1640.35-0.39%
HKSE25,633.21405.11-1.56%
NASDAQ27,093.907.090.03%
Nikkei 22568,402.131,667.892.50%
NZX 50 Index13,115.0855.63-0.42%
S&P 5007,609.789.820.13%
S&P/ASX 2008,785.705.900.07%
SSE Composite Index4,083.978.870.22%

Market Movers